Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cascara Ventures is a venture capital firm established in 2016 by Adriaan Hart de Ruijter, who has a strong background in entrepreneurship and investment within the life sciences sector. The firm is headquartered in Europe and is dedicated to investing in early-stage companies that utilize technology for prevention, therapy, and research in life sciences.
Since its inception, Cascara Ventures has focused on building a portfolio of innovative startups in the life sciences domain. The firm collaborates with a network of investors and funds, enhancing its ability to support portfolio companies as they progress through various stages of growth. As an accredited investor with the European Investment Fund, Cascara Ventures can match investments on a pari passu basis, thereby increasing its commitment to a larger number of startups.
Cascara Ventures primarily invests in seed-stage companies within the life sciences sector, targeting a diverse range of investment areas. These include vaccines, medical devices, pharmaceuticals, imaging, software, medical data, robotics, healthcare services, diagnostics, and cell therapy. The firm emphasizes early-stage investing and active management of its portfolio companies, leveraging its expertise in regulatory and clinical development to foster growth.
Cascara Ventures seeks technology-driven solutions that address critical challenges in healthcare. The firm values founders who demonstrate a strong understanding of their market and possess a clear vision for their innovations. Their investment strategy is characterized by a hands-on approach, ensuring that portfolio companies receive the necessary support to navigate the complexities of the life sciences industry.
Cascara Ventures collaborates with a network of investors and funds to support its portfolio companies through to mature stages. While specific portfolio companies are not disclosed, the firm’s focus on life sciences ensures that its investments are concentrated in areas such as biotech, healthcare, and related technologies. Their accreditation with the European Investment Fund allows them to match investments on a pari passu basis, which enhances their ability to commit to a larger number of startups.
This collaborative approach not only strengthens the financial backing of their portfolio companies but also provides access to a wealth of resources and expertise in the life sciences sector.
Adriaan Hart de Ruijter - Founder and Investor. Adriaan has extensive experience as an entrepreneur and investor in the life sciences sector. His background includes a strong focus on early-stage investments and a deep understanding of regulatory and clinical development processes.
To pitch Cascara Ventures, founders should use the contact form available on their website. A concise pitch deck is essential, detailing the business model, market opportunity, and team qualifications. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
What investment criteria does Cascara Ventures use?
Cascara Ventures focuses on seed-stage investments in the life sciences sector, particularly in technology-driven solutions. They look for companies that address significant healthcare challenges and demonstrate a clear market understanding.
How can founders pitch to Cascara Ventures?
Founders can reach out through the contact form on their website. A well-prepared pitch deck that outlines the business model, market opportunity, and team background is essential.
What makes Cascara Ventures different from other investors?
The firm emphasizes active management and has a strong focus on regulatory and clinical development, which is crucial for life sciences startups. Their collaboration with the European Investment Fund enhances their investment capabilities.
What is Cascara Ventures' geographic focus?
Cascara Ventures primarily invests in early-stage companies based in Europe, ensuring they are well-positioned to support local innovations in life sciences.
What kind of post-investment involvement can founders expect?
Cascara Ventures takes an active role in managing its portfolio companies, providing guidance in regulatory processes and clinical development, which can be critical for success in the life sciences sector.
What is the typical check size for investments?
While specific check sizes are not disclosed, Cascara Ventures focuses on seed-stage investments, which typically range from several hundred thousand to a few million euros, depending on the startup's needs and potential.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.